Nicotinic ACh receptors as therapeutic targets in CNS disorders

KT Dineley, AA Pandya, JL Yakel - Trends in pharmacological sciences, 2015 - cell.com
The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the
cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These …

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives

V Parikh, MG Kutlu, TJ Gould - Schizophrenia research, 2016 - Elsevier
Introduction The prevalence of tobacco use in the population with schizophrenia is
enormously high. Moreover, nicotine dependence is found to be associated with symptom …

[HTML][HTML] Neurobiological determinants of tobacco smoking in schizophrenia

AM Lucatch, DJE Lowe, RC Clark, K Kozak… - Frontiers in …, 2018 - frontiersin.org
Purpose of review: To provide an overview of the underlying neurobiology of tobacco
smoking in schizophrenia, and implications for treatment of this comorbidity. Recent findings …

[HTML][HTML] The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7

Y Wang, C Xiao, T Indersmitten, R Freedman… - Journal of Biological …, 2014 - ASBMB
The α7 nicotinic acetylcholine receptor gene (CHRNA7) is linked to schizophrenia. A partial
duplication of CHRNA7 (CHRFAM7A) is found in humans on 15q13–14. Exon 6 of …

[HTML][HTML] Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: a double-blind randomized trial

RC Smith, R Amiaz, TM Si, L Maayan, H Jin, S Boules… - PloS one, 2016 - journals.plos.org
Schizophrenic patients have a high rate of smoking and cognitive deficits which may be
related to a decreased number or responsiveness of nicotinic receptors in their brains …

[HTML][HTML] Impact of substance use disorder pharmacotherapy on executive function: a narrative review

K Butler, B Le Foll - Frontiers in psychiatry, 2019 - frontiersin.org
Substance use disorders are chronic, relapsing, and harmful conditions characterized by
executive dysfunction. While there are currently no approved pharmacotherapy options for …

Reduced short-latency afferent inhibition in prefrontal but not motor cortex and its association with executive function in schizophrenia: a combined TMS-EEG study

Y Noda, MS Barr, R Zomorrodi, RFH Cash… - Schizophrenia …, 2018 - academic.oup.com
Background: Cholinergic dysfunction is increasingly assumed to be involved in the
pathophysiology of schizophrenia. Short-latency afferent inhibition (SAI) is a transcranial …

The role of nicotine in schizophrenia

RE Featherstone, SJ Siegel - International review of neurobiology, 2015 - Elsevier
Schizophrenia is associated with by severe disruptions in thought, cognition, emotion, and
behavior. Patients show a marked increase in rates of smoking and nicotine dependence …

It is feasible and effective to help patients with severe mental disorders to quit smoking: an ecological pragmatic clinical trial with transdermal nicotine patches and …

MP Garcia-Portilla, L Garcia-Alvarez, F Sarramea… - Schizophrenia …, 2016 - Elsevier
Despite the proven association between smoking and high rates of medical morbidity and
reduced life expectancy in people with severe mental disorders (SMD), their smoking rates …

Cholinergic functioning, cognition, and anticholinergic medication burden in schizophrenia

YB Joshi - … Functioning in Schizophrenia: Leveraging the RDoC …, 2022 - Springer
Acetylcholine (ACh) signaling is critical for central nervous function and is known to be
abnormal in schizophrenia (SZ), a chronic neuropsychiatric disorder in which cognitive …